Tag Archives: Spectrum Pharmaceuticals

October, 2018

May, 2018

March, 2016

  • 16 March

    FDA Approves Spectrum Pharmaceuticals’ Evomela for Injection

    HENDERSON, Nev.–(BUSINESS WIRE)– Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that the U.S. Food and Drug Administration (FDA) has granted approval of EVOMELA for use in two indications: 1) use as a …

October, 2015

  • 23 October

    FDA Declines to Approve Spectrum’s Blood Cancer Drug

    HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA). A Complete Response Letter is a communication …